Long-term glycemic control using polymer-encapsulated human stem cell-derived beta cells in immune-competent mice

Nature Medicine

Volumn 22, Issue 3, 2016, Pages 306-311

  Vegas, Arturo J ^a,b,i   Veiseh, Omid ^a,b,c   Gürtler, Mads ^d   Millman, Jeffrey R ^d,j,k   Pagliuca, Felicia W ^d   Bader, Andrew R ^a,b,c   Doloff, Joshua C ^a,b   Li, Jie ^a,b   Chen, Michael ^a,b   Olejnik, Karsten ^a,b   Tam, Hok Hei ^a,b,c   Jhunjhunwala, Siddharth ^a,b   Langan, Erin ^a,b   Aresta Dasilva, Stephanie ^a,b   Gandham, Srujan ^a,b   McGarrigle, James J ^e   Bochenek, Matthew A ^e   Hollister Lock, Jennifer ^f   Oberholzer, Jose ^e   Greiner, Dale L ^g   Weir, Gordon C ^f   Melton, Douglas A ^d,h   Langer, Robert ^a,b,c   Anderson, Daniel G ^a,b,c   more..

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c Massachusetts Institute of Technology Cambridge   (United States)

^d Harvard University   (United States)

^e UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^f JOSLIN DIABETES CENTER   (United States)

^g UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^h HARVARD UNIVERSITY   (United States)

ⁱ Boston University   (United States)

^j WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^k WASHINGTON UNIVERSITY IN ST LOUIS   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALGINIC ACID; C PEPTIDE; GLUCOSE; INSULIN; POLYMER; GLUCOSE BLOOD LEVEL; HYDROGEL; MORPHOLINE DERIVATIVE; THIOMORPHOLINE; TRIAZOLE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; C57BL 6 MOUSE; CELL DIFFERENTIATION; CELL ENCAPSULATION; CELL VIABILITY; CONTROLLED STUDY; EMBRYO; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; HUMAN CELL; HUMAN EMBRYONIC STEM CELL; IMMUNE RESPONSE; IMMUNOCOMPETENCE; IN VIVO STUDY; INSULIN DEPENDENT DIABETES MELLITUS; MOUSE; NONHUMAN; OUTCOME ASSESSMENT; PANCREAS ISLET BETA CELL; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; ANIMAL; CELL CULTURE TECHNIQUE; CELL TRANSPLANTATION; CONFOCAL MICROSCOPY; CYTOLOGY; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; DISEASE MODEL; EMBRYONIC STEM CELL; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; FOREIGN-BODY REACTION; HYDROGEL; LIQUID CHROMATOGRAPHY; METABOLISM; PHASE CONTRAST MICROSCOPY; PROCEDURES; SECRETION (PROCESS); TANDEM MASS SPECTROMETRY; TRANSPLANTATION; WESTERN BLOTTING;

ALGINATES; ANIMALS; BLOOD GLUCOSE; BLOTTING, WESTERN; C-PEPTIDE; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELL TRANSPLANTATION; CHROMATOGRAPHY, LIQUID; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; DISEASE MODELS, ANIMAL; EMBRYONIC STEM CELLS; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; FOREIGN-BODY REACTION; HUMANS; HYDROGELS; IMMUNOCOMPETENCE; INSULIN; INSULIN-SECRETING CELLS; MICE; MICROSCOPY, CONFOCAL; MICROSCOPY, PHASE-CONTRAST; MORPHOLINES; POLYMERS; TANDEM MASS SPECTROMETRY; TRIAZOLES;

EID: 84955615077     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm.4030     Document Type: Article

References (35)

1. Robertson, R.P. Islet transplantation as a treatment for diabetes-A work in progress. N. Engl. J. Med. 350, 694-705 (2004
2. Shapiro, A.M. et al. International trial of the Edmonton protocol for islet transplantation. N. Engl. J. Med. 355, 1318-1330 (2006
3. Hirshberg, B. Lessons learned from the international trial of the Edmonton protocol for islet transplantation. Curr. Diab. Rep. 7, 301-303 (2007
4. Pagliuca, F.W. et al. Generation of functional human pancreatic β-cells in vitro. Cell 159, 428-439 (2014
5. Lim, F. & Sun, A.M. Microencapsulated islets as bioartificial endocrine pancreas. Science 210, 908-910 (1980
6. Soon-Shiong, P. et al. Insulin independence in a type 1 diabetic patient after encapsulated islet transplantation. Lancet 343, 950-951 (1994
7. Dolgin, E. Encapsulate this. Nat. Med. 20, 9-11 (2014
8. Shaw, J.E., Sicree, R.A. & Zimmet, P.Z. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res. Clin. Pract. 87, 4-14 (2010
9. Pickup, J.C. Insulin-pump therapy for type 1 diabetes mellitus. N. Engl. J. Med. 366, 1616-1624 (2012
10. Veiseh, O., Tang, B.C., Whitehead, K.A., Anderson, D.G. & Langer, R. Managing diabetes with nanomedicine: challenges and opportunities. Nat. Rev. Drug Discov. 14, 45-57 (2015
11. Shapiro, A.M. et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N. Engl. J. Med. 343, 230-238 (2000
12. Qi, M. et al. Five-year follow-up of patients with type 1 diabetes transplanted with allogeneic islets: the UIC experience. Acta Diabetol. 51, 833-843 (2014
13. Shapiro, A.M. Islet transplantation in type 1 diabetes: ongoing challenges, refined procedures and long-term outcome. Rev. Diabet. Stud. 9, 385-406 (2012
14. Vogel, G. Stem cell recipe offers diabetes hope. Science 346, 148 (2014
15. Jacobs-Tulleneers-Thevissen, D. et al. Sustained function of alginate-encapsulated human islet cell implants in the peritoneal cavity of mice leading to a pilot study in a type 1 diabetic patient. Diabetologia 56, 1605-1614 (2013
16. Scharp, D.W. & Marchetti, P. Encapsulated islets for diabetes therapy: history, current progress and critical issues requiring solution. Adv. Drug Deliv. Rev. 67-68, 35-73 (2014
17. Lum, Z.P. et al. Prolonged reversal of diabetic state in NOD mice by xenografts of microencapsulated rat islets. Diabetes 40, 1511-1516 (1991
18. Schneider, S. et al. Long-term graft function of adult rat and human islets encapsulated in novel alginate-based microcapsules after transplantation in immunocompetent diabetic mice. Diabetes 54, 687-693 (2005
19. Peppas, N.A., Hilt, J.Z., Khademhosseini, A. & Langer, R. Hydrogels in biology and medicine: from molecular principles to bionanotechnology. Adv. Mater. 18, 1345-1360 (2006
20. Basta, G. et al. Long-term metabolic and immunological follow-up of non-immunosuppressed patients with type 1 diabetes treated with microencapsulated islet allografts: four cases. Diabetes Care 34, 2406-2409 (2011
21. Calafiore, R. et al. Microencapsulated pancreatic islet allografts into non-immunosuppressed patients with type 1 diabetes: first two cases. Diabetes Care 29, 137-138 (2006
22. de Groot, M., Schuurs, T.A. & van Schilfgaarde, R. Causes of limited survival of microencapsulated pancreatic islet grafts. J. Surg. Res. 121, 141-150 (2004
23. Tuch, B.E. et al. Safety and viability of microencapsulated human islets transplanted into diabetic humans. Diabetes Care 32, 1887-1889 (2009
24. Elliott, R.B. et al. Intraperitoneal alginate-encapsulated neonatal porcine islets in a placebo-controlled study with 16 diabetic cynomolgus primates. Transplant. Proc. 37, 3505-3508 (2005
25. Omer, A. et al. Survival and maturation of microencapsulated porcine neonatal pancreatic cell clusters transplanted into immunocompetent diabetic mice. Diabetes 52, 69-75 (2003
26. Veiseh, O. et al. Size- and shape-dependent foreign-body immune response to materials implanted in rodents and nonhuman primates. Nat. Mater. 14, 643-651 (2015
27. Vegas, A.J. et al. Combinatorial hydrogel library enables identification of materials that mitigate the foreign-body response in primates. Nat. Biotechnol. doi: 10.1038/nbt.3462 (25 January 2016
28. Kolb, M. et al. Differences in the fibrogenic response after transfer of active transforming growth factor-β1 gene to lungs of fibrosis-prone and fibrosis-resistant mouse strains. Am. J. Respir. Cell Mol. Biol. 27, 141-150 (2002
29. Dang, T.T. et al. Spatiotemporal effects of a controlled-release anti-inflammatory drug on the cellular dynamics of host response. Biomaterials 32, 4464-4470 (2011
30. King, A., Sandler, S. & Andersson, A. The effect of host factors and capsule composition on the cellular overgrowth on implanted alginate capsules. J. Biomed. Mater. Res. 57, 374-383 (2001
31. Pepper, A.R. et al. A prevascularized subcutaneous device-less site for islet and cellular transplantation. Nat. Biotechnol. 33, 518-523 (2015
32. Lee, S.H. et al. Human beta cell precursors mature into functional insulin-producing cells in an immunoisolation device: implications for diabetes cell therapies. Transplantation 87, 983-991 (2009
33. Rezania, A. et al. Maturation of human embryonic stem cell-derived pancreatic progenitors into functional islets capable of treating pre-existing diabetes in mice. Diabetes 61, 2016-2029 (2012
34. Rezania, A. et al. Reversal of diabetes with insulin-producing cells derived in vitro from human pluripotent stem cells. Nat. Biotechnol. 32, 1121-1133 (2014
35. Wang, T. et al. An encapsulation system for the immunoisolation of pancreatic islets. Nat. Biotechnol. 15, 358-362 (1997